These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12720542)
21. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome. Blum I; Lerman M; Misrachi I; Nordenberg Y; Grosskopf I; Weizman A; Levy-Schiff R; Sulkes J; Vered Y Neuropsychobiology; 2004; 50(1):10-5. PubMed ID: 15179014 [TBL] [Abstract][Full Text] [Related]
22. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. Schmidt PJ; Nieman LK; Grover GN; Muller KL; Merriam GR; Rubinow DR N Engl J Med; 1991 Apr; 324(17):1174-9. PubMed ID: 2011161 [TBL] [Abstract][Full Text] [Related]
23. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. Wihlbäck AC; Sundström-Poromaa I; Nyberg S; Bäckström T Neuroendocrinology; 2001 Jun; 73(6):397-407. PubMed ID: 11408781 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550 [TBL] [Abstract][Full Text] [Related]
26. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. Leather AT; Studd JW; Watson NR; Holland EF Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798 [TBL] [Abstract][Full Text] [Related]
27. Essential fatty acids in the treatment of premenstrual syndrome. Collins A; Cerin A; Coleman G; Landgren BM Obstet Gynecol; 1993 Jan; 81(1):93-8. PubMed ID: 8416468 [TBL] [Abstract][Full Text] [Related]
28. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325 [TBL] [Abstract][Full Text] [Related]
29. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Heinrich AB; Wolf OT Neuropsychobiology; 2005; 52(1):17-23. PubMed ID: 15942259 [TBL] [Abstract][Full Text] [Related]
30. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group. Magill PJ Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838 [TBL] [Abstract][Full Text] [Related]
31. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Chan AF; Mortola JF; Wood SH; Yen SS Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. Girdler SS; O'Briant C; Steege J; Grewen K; Light KC J Womens Health Gend Based Med; 1999 Jun; 8(5):637-46. PubMed ID: 10839650 [TBL] [Abstract][Full Text] [Related]
33. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. Vanselow W; Dennerstein L; Greenwood KM; de Lignieres B J Psychosom Obstet Gynaecol; 1996 Mar; 17(1):29-38. PubMed ID: 8860884 [TBL] [Abstract][Full Text] [Related]
34. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. Seippel L; Bäckström T J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129 [TBL] [Abstract][Full Text] [Related]
35. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Wang M; Hammarbäck S; Lindhe BA; Bäckström T Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564 [TBL] [Abstract][Full Text] [Related]
36. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K Menopause; 2008; 15(1):51-8. PubMed ID: 18257142 [TBL] [Abstract][Full Text] [Related]
37. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Fanaei H; Khayat S; Kasaeian A; Javadimehr M Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718 [TBL] [Abstract][Full Text] [Related]
38. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
39. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683 [TBL] [Abstract][Full Text] [Related]
40. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women. Limpaphayom KK; Bunyavejchevin S J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]